T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP

T cell clones raised against a synthetic peptide, identical to the third hypervariable region of the DR3 BI chain, were tested for secondary proliferative responses against a panel of PBLs. All seven DR3 DPw3+ stimulators could induce proliferation. DR3- DPw3+ PBLs were recognized when the synthetic peptide was added to the cultures. Inhibition studies with mAbs showed that in both cases the HLA-DP molecule is involved in the recognition of both types of stimulators. We conclude that the clones recognize the DR3 peptide presented by HLA- DPw3. This stimulus can be obtained in two different ways: (a) by addition of synthetic peptide to DPw3+ PBLs or (b) by using DR3 DPw3+ stimulator cells where DR3 peptides are present in the culture as a product of denaturation of the DR3 molecule. Because all DR3 DPw3+ PBLs tested could stimulate the line and clones, we assume that the presentation of the DR3 peptide by DP is a naturally and continuously occurring phenomenon.

[1]  D. Anderson,et al.  A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. , 1988, Science.

[2]  F. Claas,et al.  Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. , 1988, Science.

[3]  J. Cerottini,et al.  Synthetic peptides as antigens and competitors in recognition by H-2- restricted cytolytic T cells specific for HLA , 1988, The Journal of experimental medicine.

[4]  P. Parham,et al.  HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes , 1987, Nature.

[5]  J. Claverie,et al.  Working principles in the immune system implied by the "peptidic self" model. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Parham,et al.  Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. , 1987, Nature.

[7]  B. Jordan,et al.  H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide , 1986, Nature.

[8]  B. Mach,et al.  Polymorphism of human Ia antigens: gene conversion between two DR β loci results in a new HLA-D/DR specificity , 1986, Nature.

[9]  J. Claverie,et al.  The peptidic self model: a hypothesis on the molecular nature of the immunological self. , 1986, Annales de l'Institut Pasteur. Immunology.

[10]  R. Houghten.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Grey,et al.  Antigen processing and presentation to T cells. , 1985, Immunology today.

[12]  E. Unanue.  Antigen-presenting function of the macrophage. , 1984, Annual review of immunology.

[13]  J. Coligan,et al.  HLA‐DC antigens can serve as recognition elements for human cytotoxic T lymphocytes , 1984, European journal of immunology.

[14]  E. Unanue,et al.  Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. , 1981, Journal of immunology.

[15]  J. Meienhofer,et al.  Special methods in peptide synthesis , 1980 .